This second of our special health-care series concerns health care mergers, perhaps the thorniest antitrust issue that ObamaCare presents. While the ACA encourages cost savings through ACOs and other means, the antitrust authorities continue to be skeptical of health care institution mergers. Do all health care mergers fall between a rock and a hard place? Our experts present explanations and practical answers. (For those of you who missed Part 1 of our series on Reverse Payments, check it out here.) And we’ve added a special article on LIBOR to make certain our readers are up to date on that scandal. Enjoy!

Health Care Mergers – Between a Rock and a Hard Place

Jeffrey Brennan, Ashley Fischer, David Marx, Jul 17, 2012

When the Antitrust Laws May Not Allow Healthcare Providers to Pursue Merger-Specific Efficiencies And What Healthcare Providers Can Do About It

If carefully structured, virtually all health care organizations have opportunities through collaborations to achieve their strategic goals. Ashley Fischer, Jeffrey Brennan & David Marx (McDermott, Will, and Emery)

Lona Fowdur, John Gale, Jul 17, 2012

Health Care Reform, Provider Affiliations, and Antitrust Risks

Given that many types of affiliations are only just getting off the ground, there is little precedent on the basis of which to gauge what the Agencies enforcement policies will be. John Gale & Lona Fowdur (Economists Incorporated)

Robert Leibenluft, Jul 17, 2012

The Changing Health Care Sector: Tough New Challenges for Antitrust Enforcers

Changes in the health care sector will require antitrust enforcers and health care regulators to apply more sophisticated approaches to ensure that our reliance on competitive health care markets is well-placed. Robert F. Leibenluft (Hogan Lovells)

David Pearl, Toby Singer, Jul 17, 2012

Between the ACA and Antitrust Enforcers: A Rock and a Hard Place or an Opportunity?

Not all consolidation is created equal. Toby G. Singer & David Pearl (Jones Day)

Melissa Davenport, Ryan McManus, Jane Willis, Jul 17, 2012

Healthcare Reform and Antitrust Enforcement: Provider Consolidation Encouraged, Scrutinized

The landscape is shifting in ways that will make it increasingly difficult for smaller players to remain independent and the antitrust agencies may ultimately need to adapt. Jane Willis, Melissa Davenport, & Ryan McManus (Ropes & Gray)

The LIBOR Scandal

Rosa Abrantes-Metz, Jul 17, 2012

Why and How Should the Libor Be Reformed?

The Libor process has considerable problems, creating the ability, the means, and the incentive to create distortions. Rosa Abrantes-Metz (Global Economics Group)